Hospital Access Patient Assistance Program (HAPAP)

This program allows eligible hospitals to receive free medications to give to qualified outpatients directly.

Hospitals can apply for this program if they’re currently enrolled in the 340B Drug Pricing Program, which requires drug manufactureres to provide outpatient medications at reduced prices. To apply, hospitals must also be classified as a Disproportionate Share Hosptial (a hospital that treats patients who don’t have insurance or aren’t eligible for other health care coverage).

Hospitals that participate in this program are required to sign a contract and agree to on-site assessments.

The program includes these medications:

EDURANT®
(rilpivirine) Tablets

INTELENCE®
(etravirine) Tablets

INVOKAMET® †
(canagliflozin/metformin HCI) Tablets

INVOKAMET® XR
(canagliflozin/metformin HCI) Tablets

INVOKANA®
(canagliflozin) Tablets

PREZCOBIX®
(darunavir 800mg/cobicistat 150mg) Tablets

PREZISTA®
(darunavir) Tablets

SYMTUZA™
(darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) Tablets

XARELTO® †
(rivaroxaban) Tablets

† Please see full U.S. prescribing information, including Black Box warning for: INVOKAMET®, INVOKAMET® XR, INVOKANA®, XARELTO®

Hospitals can apply online via the HAPAP Portal.